Water-Soluble Nanoconjugate for Enhanced Cellular Delivery of Receptor-Targeted Magnetic Resonance Contrast Agents
- 7 October 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 30 (11) , 2947-2957
Abstract
ProGlo is an efficient steroid receptor-targeted magnetic resonance (MR) imaging contrast agent (CA). It has been shown to bind to the progesterone receptor (PR) and produce enhanced image contrast in PR-positive cells and tissues in vitro and in vivo. However, the hydrophobicity of the steroid targeting domain of ProGlo (logP = 1.4) limits its formulation and delivery at clinically relevant doses. In this work, a hydrophobic moiety was utilized to drive efficient adsorption onto nanodiamond (ND) clusters to form a water-soluble nanoconstruct (logP = −2.4) with 80% release in 8 h under biological conditions. In cell culture, the ND-ProGlo construct delivered increased concentrations of ProGlo to target cells compared to ProGlo alone. Importantly, these results were accomplished without the use of solvents such as DMSO, providing a significant advance toward formulating ProGlo for translational applications. Biodistribution studies confirm the delivery of ProGlo to PR(+) tissues with enhanced efficacy over untargeted controls. These results demonstrate the potential for a noncovalent ND-CA construct as a general strategy for solubilizing and delivering hydrophobic targeted MR CAs.Keywords
Funding Information
- National Cancer Institute (1F30CA174156- 01)
- Wallace H. Coulter Foundation
- National Center for Complementary and Integrative Health (R01AT008824-1)
- National Institute of Biomedical Imaging and Bioengineering (R01EB005866, R01EB014806)
- V Foundation for Cancer Research
This publication has 52 references indexed in Scilit:
- Synthesis and Biological Evaluation of Water-Soluble Progesterone-Conjugated Probes for Magnetic Resonance Imaging of Hormone Related CancersBioconjugate Chemistry, 2011
- A Steroid-Conjugated Magnetic Resonance Probe Enhances Contrast in Progesterone Receptor Expressing Organs and Tumors in VivoMolecular Pharmaceutics, 2011
- A Modular System for the Synthesis of Multiplexed Magnetic Resonance ProbesJournal of the American Chemical Society, 2011
- Steroid hormone receptors in cancer development: A target for cancer therapeuticsCancer Letters, 2011
- Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cellsBiomaterials, 2009
- Bioresponsive, Cell-Penetrating, and Multimeric MR Contrast AgentsAccounts of Chemical Research, 2009
- Multimodal MRI contrast agentsJBIC Journal of Biological Inorganic Chemistry, 2007
- Characterization and application of single fluorescent nanodiamonds as cellular biomarkersProceedings of the National Academy of Sciences, 2007
- Bright Fluorescent Nanodiamonds: No Photobleaching and Low CytotoxicityJournal of the American Chemical Society, 2005
- Estrogen and progesterone receptors in endometrial cancer and their prognostic relevanceGynecologic Oncology, 1990